Atlas Trials

Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

Clinical trial NCT07700446 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07700446
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis (UC)
Start date
2026-11-15
Primary completion
2029-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.